Modulation of the endogenous Annexin A1 in a cigarette smoke cessation model: Potential therapeutic target in reversing the damage caused by smoking?-Reference-Cited by-同舟云学术

Modulation of the endogenous Annexin A1 in a cigarette smoke cessation model: Potential therapeutic target in reversing the damage caused by smoking?

Published:2019-10 Issue:10 Volume:215 Page:152614
ISSN:0344-0338
Container-title:Pathology - Research and Practice
language:en
Short-container-title:Pathology - Research and Practice

Author:

Lebron Isabella de Souza Lima,da Silva Ligia Furlan,Paletta Julia Tagliaferri,da Silva Rafael André,Sant’Ana Monielle,Costa Sara de Souza,Iyomasa-Pilon Melina Mizusaki,Souza Helena Ribeiro,Possebon Lucas,Girol Ana Paula

Publisher

Elsevier BV

Subject

Cell Biology,Pathology and Forensic Medicine

Reference47 articles.

1. Concerns regarding tobacco use;Pan American Health Organization and World Health Organization;Int. Q. Commun. Health Educ.,2012

2. The Novartis view on emerging drugs and novel targets for the treatment of chronic obstructive pulmonary disease;Compton;Pulm. Pharmacol. Ther.,2013

3. Cytokine inhibition in the treatment of COPD;Caramori;Int. J. Chron. Obstruct. Pulmon. Dis.,2014

4. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report: GOLD executive summary;Vogelmeier;Eur. Respir. J.,2017

5. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary;Rabe;Am. J. Respir. Crit. Care Med.,2007

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Protective effects of piperlongumin in the prevention of inflammatory damage caused by pulmonary exposure to benzopyrene carcinogen;International Immunopharmacology;2021-12